Clinical trial
TS Overexpression in SCLC: Mechanism and Therapeutic Targeting
NCT03741829
Study timeline
Study start (actual)2017-06-14Date precision: day
Registry last updated2020-02-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03741829 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.